Navigation Links
Replacement Burr Set

ProductsReplacement Burr Set
Company Bausch & Lomb Storz
Item Replacement Burr Set
Features 
Description Set of six replacement burrs for E0824 Storz corneal burr set. Dull finish. Most popular size or model.
Info Bausch & Lomb Storz
Customer Service: (585) 338-6000
Web site: http://www.storz.com/

Related medicine products :

1. Replacement Burr/Chuck
2. Replacement Burr
3. Replacement Needle Tip
4. Replacement Gouge Tip
5. Replacement Handle
6. Snare Wire Replacements for E3525 3/package
7. Healos Bone Graft Replacement
8. Verte-Span Vertebral Body Replacement
9. Vertebral Body Replacement (VBR)
10. Perfecta PDA Calcar Replacement Stems
11. S-ROM Femoral Stems - Standard Length Stems 36mm Neck with +21mm Calcar Replacement
The OX-2 is configured asstandalone or handheld unit, designed for hospital, transport and home use.
The 8600 Series Tabletop/Portable Digital Pulse Oximeter provides a simple universal tool for patient monitering. From transport applications to continuous monitoring, the 8600 has earned the confide
Halogen-free immersion oil based on ester oil.
Immersion oil composed on polyester polyol, diphenyl cresyl phosphate and tricyclodecane dimethanol.
Medicine Products:
(Date:5/20/2008)...nical settings, DNA microarrays are currently unsu...on formalin-fixed paraffin-embedded tissues is req...markers for identifying the prognosis of gastric c...eam led by Professor Zhong-Sheng Zhao, is describe..., 2008 in the World Journal of Gastroenterology. ,...
(Date:5/20/2008)...nd-stage liver disease would benefit from liver su...tion of hepatic functions or to enable bridging to...patients, general condition, including cardiovascu...patic encephalopathy. Studies evaluating the hemod...is during extra-corporal intervention remain scarc...
(Date:5/20/2008)...H+ exchanger (NHE1) is a transmembrane protein fou...s to evacuate excessive H+ in the cytoplasm by mea...llular pH value. Inhibition of the upregulation of...cells can induce intracellular acidification, resu...l for the treatment of tumors. , This study, per...
(Date:5/20/2008)...., May 20 /PRNewswire-FirstCall/ -- Perrigo Compan...ph C. Papa, Perrigo,s,Chairman and CEO will presen...re Conference on Wednesday, May 21, at 10:00 a.m. ... be webcast on the following link, http://www.vera...cfm ., Perrigo Company is a leading global healt...
Breaking Medicine News(10 mins):
... are insufficient doctors specializing in sports m...012 Olympics// that is to be hosted by UK. Present...o recruit one specialist each, for the treatment o... as to help tackle the rising problem of obesity. ...
...revention of chikungunya and dengue fever in the s...blic Health//. Aedes aegypti, mosquito is the com...dengue causing virus. Hence, the state has taken u...me involving 35,000 health workers and volunteers....
...urvey has revealed that extreme and prolonged stre... by an inability to switch off, could lead to grav...e survey also found that not being able to sleep i... rigors of coping with every day life. They are no...
...ons commonly sold on the street, causes the abnorm... a process causing heart enlargement that can ulti...at the University of South Florida College of Medi...ital. The study was published in the July 2006 is...
Other Medicine News:Health News:Sports Doctors too few for 2012 Olympics 2Health News:Researchers Identify Key Step in Cocaine-Induced Heart Enlargement, Sudden Death 2
(Date:5/20/2008)...RNewswire-FirstCall/ -- BioMarin,Pharmaceutical In... first,patient has initiated treatment in the Phas...nt phenylalanine ammonia lyase) for the treatment ... conclude enrollment in the,fourth quarter of 2008... and hope to address the,entire spectrum of PKU pa...
(Date:5/20/2008)...lysis of US Employer Claims Suggests a Benefit,of ...m Among Employees with Infla...ire/ -- Data from a new analysis of the,Active Ulc...at at week 8,more than 60 percent of patients wit... (UC) receiving REMICADE(R) (infliximab) achieved,...
(Date:5/20/2008)...ith HALO device leads to 100% patient response ...lif., May 20 /- BARRX Medical, Inc., ...sophagus, today announced the,publication of two r...tion,rate for early esophageal cancer and pre-canc...d by ablation therapy with the HALO ablation,syste...
(Date:5/20/2008)...RNewswire-FirstCall/ -- Palatin Technologies,Inc....n initiated in a Phase,2a clinical study of PL-399...or A agonist, in subjects with controlled hyperten...-blinded, and will include up,to five cohorts rece...l be,included, with six active subjects and one pl...
Breaking Medicine Technology:BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU 2BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU 3New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 2New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 3New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 4New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 5New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 6New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 7New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 8Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination 2Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination 3Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994 2Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994 3Dr Fay Raines From the University of Alabama in Huntsville Assumes Presidency of the American Association of Colleges of Nursing 16736 1Dr Fay Raines From the University of Alabama in Huntsville Assumes Presidency of the American Association of Colleges of Nursing 16736 2Dr Fay Raines From the University of Alabama in Huntsville Assumes Presidency of the American Association of Colleges of Nursing 16736 3Dr Fay Raines From the University of Alabama in Huntsville Assumes Presidency of the American Association of Colleges of Nursing 16736 4U S Pharmacopeia Aiding FDA in Improved Tests for Heparin Contamination 16733 1U S Pharmacopeia Aiding FDA in Improved Tests for Heparin Contamination 16733 2CVS Caremark Charity Classic Golf Tournament Unveils 10th Anniversary Field 16730 1CVS Caremark Charity Classic Golf Tournament Unveils 10th Anniversary Field 16730 2CVS Caremark Charity Classic Golf Tournament Unveils 10th Anniversary Field 16730 3Northwest Hospital 26 Medical Center Hosts Health 26 Wellness Pavilion At Second Annual King 5 Healthy Living Expo 16727 1Northwest Hospital 26 Medical Center Hosts Health 26 Wellness Pavilion At Second Annual King 5 Healthy Living Expo 16727 2
...April 12, 2007,/PRNewswire-FirstCall/ -- Data anal...l trial program ever undertaken in the renal,anemi... the,investigational anemia therapy MIRCERA(TM) fo...ronic kidney disease (CKD) in,patients on dialysis...sented at the National Kidney Foundation 2007 Spri...
... /PRNewswire/ -- Mersana, a,cancer therapeutics co... studies with its lead product candidate, XMT-1001...ual Meeting of the,American Association of Cancer ...Angeles, CA. Full text of the abstracts can be,vie...k" href=,"http://www.aacr.org/">http://www.AACR.or...
Other Medicine Technology:Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 2Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 3Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 4Mersana Therapeutics, Inc. to Present Preclinical Data on XMT-1001,at American Association of Cancer Research Annual Meeting 2